Therapeutic responses to different antimalarial drugs in vivax malaria

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1680-1685

  Pukrittayakamee, Sasithon ^a   Chantra, Arun ^a   Simpson, Julie A ^a,b   Vanijanonta, Sirivan ^a   Clemens, Ralf ^a,c   Looareesuwan, Sornchai ^a   White, Nicholas J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTESUNATE; CHLOROQUINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PARACETAMOL; PRIMAQUINE; QUININE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITEMIA; PLASMODIUM VIVAX; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT OUTCOME;

ADULT; ANIMALS; ANTIMALARIALS; HUMANS; MALARIA, VIVAX; MALE; PLASMODIUM VIVAX; TREATMENT OUTCOME;

EID: 0034079397     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1680-1685.2000     Document Type: Article

References (14)

1. Baird, J. K., B. Leksana, S. Masbar, D. J. Fryauff, A. M. Sutanihardja, Suradi, F. S. Wingnall, and S. L. Huffman. 1997. Diagnosis of resistance to chloroquine by Plasmoduim vivax: timing of recurrence and whole blood chloroquine levels. Am. J. Trop. Med. Hyg. 56:621-626.
2. Collins, W., and G. M. Jeffery. 1996. Primaquine resistance in Plasmodium vivax. Am. J. Trop. Med. Hyg. 55:243-249.
3. de Pecoulas, P. E., R. Tahar, T. Ouatas, A. Mazabraud, and L. K. Basco. 1998. Sequence variations in the Plasmodium vivax dihydrofolate reductasethymidylate synthase gene and their relationship with pyrimethamine resistance. Mol. Biochem. Parasitol. 92:265-273.
4. Kirchgatter, K., and H. A. del Portillo. 1998. Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker. J. Infect. Dis. 117:511-515.
5. Luxemburger, C., M. van Vugt, S. Jonathan, R. MeGready, S. Looareesuwan, N. J. White, and F. Nosten. 1999. Treatment of vivax malaria in an endemic area on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:433-438.
6. Most, H., I. M. London, C. A. Kane, P. H. Lavietes, and E. F. Schroeder. 1946. Chloroquine for treatment of acute attacks of vivax malaria. JAMA 131:963-967.
7. Peters, W. 1987. Experimental resistance. III. Sulphonamides, sulphones and related compounds, p. 481-522. In W. Peters (ed.), Chemotherapy and drug resistance in malaria, 2nd ed. Academic Press, London, United Kingdom.
8. Price, R. N., F. Noslen, C. Luxemburger, M. van Vugt, L. Paiphun, T. Chongsuphajaisiddhi, and N. J. White. 1997. Artesunate-mefloquine treatment of 1967 patients with multi-drug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 91:574-577.
9. Pukrittayakamee, S., A. Chantra, S. Vanijanonta, and N. J. White. 1998. Pulmonary oedema in vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 92: 421-422.
10. Pukrittayakamee, S., S. Vanijanonta, A. Chantra, R. Clemens, and N. J. White. 1994. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J. Infect. Dis. 169:932-935.
11. Schmidt, L. H. 1981. Comparative efficacies of quinine and chloroquine as companions to primaquine curative drug regimen. Am. J. Trop. Med. Hyg. 30:20-25.
12. ter Kuile, F., N. J. White, P. Holloway, G. Pasvol, and S. Krishna. 1993. Plasmodium falcipanun: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. 76:85-95.
13. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
14. White, N. J., S. Krishna, D. Waller, C. Craddock, D. Kwiatkowski, and D. Brewster. 1989. Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine-sensitive falciparum malaria. Lancet ii:1313-1316